| Hypertension | Diabetes | ||||||
---|---|---|---|---|---|---|---|---|
 | Drug treatment * | No treatment | % untreated | Multivariate adjusted OR (95% CI)*** | Treatment** | No treatment | % untreated | Multivariate adjusted OR (95% CI) *** |
Number | 323 | 1868 | Â | Â | 196 | 91 | Â | Â |
Rural | 191 | 621 | 76% | Baseline | 86 | 59 | 41% | Baseline |
Urban | 132 | 1247 | 90% | 1.6 (1.2-2.1) | 110 | 32 | 23% | 2.0 (1.1-3.8) |
Language | Â | Â | Â | Â | Â | Â | Â | Â |
Kikuyu | 232 | 1213 | 84% | Baseline | 152 | 69 | 31% | Baseline |
Kalenjin | 20 | 400 | 95% | 0.5 (0.3-0.8) | 15 | 10 | 40% | 0.9 (0.3-2.1) |
Other | 72 | 255 | 78% | 1.3 (0.9-1.8) | 29 | 12 | 29% | 0.9 (0.4-2.0) |
Age | Â | Â | Â | Â | Â | Â | Â | Â |
50-59 | 128 | 726 | 85% | Baseline | 67 | 40 | 37% | Baseline |
60-69 | 107 | 561 | 84% | 1.7 (1.2-2.3) | 74 | 29 | 28% | 1.9 (1.0-3.5) |
70-79 | 57 | 357 | 86% | 2.0 (1.4-3.0) | 34 | 12 | 26% | 3.3 (1.4-7.9) |
≥80 | 31 | 224 | 88% | 2.0 (1.2-3.3) | 21 | 10 | 32% | 2.6 (0.9-7.3) |
Male | 93 | 923 | 91% | Baseline | 92 | 47 | 34% | Baseline |
Female | 230 | 945 | 80% | 3.4 (2.5-4.5) | 104 | 44 | 30% | 1.8 (1.0-3.1) |
SES score | Â | Â | Â | Â | Â | Â | Â | Â |
1 (poorest) | 23 | 456 | 95% | Baseline | 14 | 11 | 44% | Baseline |
2 | 39 | 456 | 92% | 1.4 (0.8-2.3) | 19 | 22 | 54% | 0.7 (0.3-2.1) |
3 | 87 | 493 | 85% | 2.7 (1.7-4.4) | 60 | 24 | 29% | 2.3 (0.9-5.9) |
4 (richest) | 169 | 456 | 73% | 4.7 (2.9-7.7) | 102 | 33 | 24% | 2.2 (0.8-5.8) |
Schooling | Â | Â | Â | Â | Â | Â | Â | Â |
Any | 249 | 1217 | 83% | 1.3 (1.1-1.5) | 41 | 24 | 37% | 1.2 (0.8-1.8) |
None | 74 | 651 | 90% | Baseline | 155 | 67 | 30% | Baseline |